In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism - Université Paris-Est-Créteil-Val-de-Marne
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2019

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

A. Bidaud
  • Fonction : Auteur
F. Botterel
A. Chowdhary

Résumé

Candida auris is an emerging, multidrug-resistant pathogen responsible for invasive hospital-acquired infections. Flucytosine is an effective anti- Candida species drug, but which cannot be used as a monotherapy because of the risk of development of resistant mutants during treatment. It is, therefore, noteworthy to test possible combinations with flucytosine that may have a synergistic interaction.
Fichier principal
Vignette du fichier
bidaud-et-al-2019-in-vitro-antifungal-combination-of-flucytosine-with-amphotericin-b-voriconazole-or-micafungin-against.pdf (815.96 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03997625 , version 1 (04-09-2024)

Identifiants

Citer

A. Bidaud, F. Botterel, A. Chowdhary, E. Dannaoui. In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism. Antimicrobial Agents and Chemotherapy, 2019, 63 (12), ⟨10.1128/AAC.01393-19⟩. ⟨hal-03997625⟩
41 Consultations
1 Téléchargements

Altmetric

Partager

More